PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein

10.1038/s41467-019-10127-x

Saved in:

Bibliographic Details
Main Authors:	Thura M., Al-Aidaroos A.Q., Gupta A., Chee C.E., Lee S.C., Hui K.M., Li J., Guan Y.K., Yong W.P., So J., Chng W.J., Ng C.H., Zhou J., Wang L.Z., Yuen J.S.P., Ho H.S.S., Yi S.M., Chiong E., Choo S.P., Ngeow J., Ng M.C.H., Chua C., Yeo E.S.A., Tan I.B.H., Sng J.X.E., Tan N.Y.Z., Thiery J.P., Goh B.C., Zeng Q.
Other Authors:	CANCER SCIENCE INSTITUTE OF SINGAPORE
Format:	Article
Published:	Nature Publishing Group 2020
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/175940
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-175940
record_format	dspace
spelling	sg-nus-scholar.10635-1759402024-04-25T02:39:06Z PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein Thura M. Al-Aidaroos A.Q. Gupta A. Chee C.E. Lee S.C. Hui K.M. Li J. Guan Y.K. Yong W.P. So J. Chng W.J. Ng C.H. Zhou J. Wang L.Z. Yuen J.S.P. Ho H.S.S. Yi S.M. Chiong E. Choo S.P. Ngeow J. Ng M.C.H. Chua C. Yeo E.S.A. Tan I.B.H. Sng J.X.E. Tan N.Y.Z. Thiery J.P. Goh B.C. Zeng Q. CANCER SCIENCE INSTITUTE OF SINGAPORE BIOCHEMISTRY MEDICINE PHARMACOLOGY PHARMACY SURGERY DUKE-NUS MEDICAL SCHOOL INSTITUTE OF MOLECULAR & CELL BIOLOGY 10.1038/s41467-019-10127-x Nature Communications 10 1 2020-09-11T11:02:13Z 2020-09-11T11:02:13Z 2019 Article Thura M., Al-Aidaroos A.Q., Gupta A., Chee C.E., Lee S.C., Hui K.M., Li J., Guan Y.K., Yong W.P., So J., Chng W.J., Ng C.H., Zhou J., Wang L.Z., Yuen J.S.P., Ho H.S.S., Yi S.M., Chiong E., Choo S.P., Ngeow J., Ng M.C.H., Chua C., Yeo E.S.A., Tan I.B.H., Sng J.X.E., Tan N.Y.Z., Thiery J.P., Goh B.C., Zeng Q. (2019). PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein. Nature Communications 10 (1). ScholarBank@NUS Repository. https://doi.org/10.1038/s41467-019-10127-x 20411723 https://scholarbank.nus.edu.sg/handle/10635/175940 Nature Publishing Group Scopus
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
description	10.1038/s41467-019-10127-x
author2	CANCER SCIENCE INSTITUTE OF SINGAPORE
author_facet	CANCER SCIENCE INSTITUTE OF SINGAPORE Thura M. Al-Aidaroos A.Q. Gupta A. Chee C.E. Lee S.C. Hui K.M. Li J. Guan Y.K. Yong W.P. So J. Chng W.J. Ng C.H. Zhou J. Wang L.Z. Yuen J.S.P. Ho H.S.S. Yi S.M. Chiong E. Choo S.P. Ngeow J. Ng M.C.H. Chua C. Yeo E.S.A. Tan I.B.H. Sng J.X.E. Tan N.Y.Z. Thiery J.P. Goh B.C. Zeng Q.
format	Article
author	Thura M. Al-Aidaroos A.Q. Gupta A. Chee C.E. Lee S.C. Hui K.M. Li J. Guan Y.K. Yong W.P. So J. Chng W.J. Ng C.H. Zhou J. Wang L.Z. Yuen J.S.P. Ho H.S.S. Yi S.M. Chiong E. Choo S.P. Ngeow J. Ng M.C.H. Chua C. Yeo E.S.A. Tan I.B.H. Sng J.X.E. Tan N.Y.Z. Thiery J.P. Goh B.C. Zeng Q.
spellingShingle	Thura M. Al-Aidaroos A.Q. Gupta A. Chee C.E. Lee S.C. Hui K.M. Li J. Guan Y.K. Yong W.P. So J. Chng W.J. Ng C.H. Zhou J. Wang L.Z. Yuen J.S.P. Ho H.S.S. Yi S.M. Chiong E. Choo S.P. Ngeow J. Ng M.C.H. Chua C. Yeo E.S.A. Tan I.B.H. Sng J.X.E. Tan N.Y.Z. Thiery J.P. Goh B.C. Zeng Q. PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
author_sort	Thura M.
title	PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
title_short	PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
title_full	PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
title_fullStr	PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
title_full_unstemmed	PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
title_sort	prl3-zumab as an immunotherapy to inhibit tumors expressing prl3 oncoprotein
publisher	Nature Publishing Group
publishDate	2020
url	https://scholarbank.nus.edu.sg/handle/10635/175940
_version_	1800914404684857344

PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein

Similar Items